| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 254.39M | 210.84M | 396.57M | 341.33M | 689.91M | 2.13B |
| Gross Profit | 62.78M | -35.49M | -63.54M | 89.90M | 465.41M | 1.02B |
| EBITDA | -139.33M | -651.93M | -871.38M | -130.08M | -417.54M | 624.10M |
| Net Income | -739.99M | -590.69M | -932.05M | -966.29M | -928.11M | 37.45M |
Balance Sheet | ||||||
| Total Assets | 13.28B | 12.24B | 14.16B | 15.83B | 19.07B | 21.52B |
| Cash, Cash Equivalents and Short-Term Investments | 1.97B | 1.66B | 2.44B | 3.39B | 5.33B | 5.74B |
| Total Debt | 1.50B | 2.91B | 3.87B | 4.26B | 5.46B | 7.15B |
| Total Liabilities | 4.03B | 3.50B | 4.63B | 5.08B | 6.57B | 8.44B |
| Stockholders Equity | 8.00B | 7.61B | 8.24B | 9.27B | 10.72B | 11.31B |
Cash Flow | ||||||
| Free Cash Flow | -209.51M | -306.65M | -371.35M | -130.99M | -83.53M | -165.45M |
| Operating Cash Flow | -287.83M | -305.76M | -371.11M | -126.34M | -81.15M | -150.47M |
| Investing Cash Flow | 89.97M | 376.26M | -51.51M | -60.06M | 3.10B | 931.26M |
| Financing Cash Flow | -748.17M | -984.91M | -422.79M | -1.62B | -1.85B | -101.01M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
58 Neutral | HK$647.85M | -1.27 | -10.79% | 6.00% | -4.53% | -22.06% | |
51 Neutral | HK$701.15M | -5.74 | -2.93% | 3.28% | 178.97% | -2829.91% | |
51 Neutral | HK$661.64M | -1.75 | -4.58% | 3.48% | -4.31% | 19.29% | |
42 Neutral | HK$390.90M | -7.18 | 0.63% | 1.20% | -8.52% | ― | |
39 Underperform | HK$551.94M | -0.85 | -7.61% | ― | -7.97% | 19.98% |
Chuang’s Consortium International Limited has announced a board meeting scheduled for November 27, 2025, in Hong Kong. The meeting will address the company’s interim results for the six months ending September 30, 2025, and consider the payment of dividends, which could impact the company’s financial strategy and shareholder returns.
The most recent analyst rating on (HK:0367) stock is a Sell with a HK$0.50 price target. To see the full list of analyst forecasts on Chuang’s Consortium International stock, see the HK:0367 Stock Forecast page.
Chuang’s Consortium International Limited announced an expected reduction in losses for the six months ending September 30, 2025. The anticipated loss ranges between HK$225 million to HK$265 million, compared to a loss of HK$293 million in the previous period. This improvement is attributed to a decrease in fair value loss of investment properties and impairment provisions for properties under development, despite a net loss from the disposal of a subsidiary holding an investment property.
The most recent analyst rating on (HK:0367) stock is a Sell with a HK$0.50 price target. To see the full list of analyst forecasts on Chuang’s Consortium International stock, see the HK:0367 Stock Forecast page.
Chuang’s Consortium International Limited has announced the completion of a very substantial disposal involving the sale of a share and a loan. The company received HK$538 million in cash, with HK$193 million used to repay a bank loan and interest. As a result of this transaction, the target company is no longer a subsidiary of Chuang’s Consortium, potentially impacting its operational structure and market positioning.
The most recent analyst rating on (HK:0367) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Chuang’s Consortium International stock, see the HK:0367 Stock Forecast page.
Chuang’s Consortium International Limited recently held its Annual General Meeting (AGM) on September 15, 2025, where all proposed resolutions were approved. This included the retirement of two Independent Non-Executive Directors, Mr. Yau Chi Ming and Mr. David Chu Yu Lin, and the election of Mr. Andrew Fan Chun Wah as a new Independent Non-Executive Director. Mr. Fan will also serve on the audit, remuneration, and nomination committees. The AGM was conducted virtually, and all resolutions were passed with overwhelming support from shareholders, indicating strong backing for the company’s governance and strategic direction.
The most recent analyst rating on (HK:0367) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Chuang’s Consortium International stock, see the HK:0367 Stock Forecast page.
Chuang’s Consortium International Limited has announced the composition of its Board of Directors, which includes both executive and independent non-executive directors. The Board has also established four committees: Audit, Remuneration, Nomination, and Corporate Governance, with specific directors assigned as chairmen and members of these committees. This announcement reflects the company’s commitment to structured governance and oversight, potentially impacting its operational efficiency and stakeholder confidence.
The most recent analyst rating on (HK:0367) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Chuang’s Consortium International stock, see the HK:0367 Stock Forecast page.
Chuang’s Consortium International Limited announced that the proposed resolution regarding the Sale and Purchase Agreement was successfully passed at the Special General Meeting held on 2 September 2025. The resolution received overwhelming support with 99.99% of votes in favor, indicating strong shareholder backing for the transaction. This approval authorizes the company’s directors to proceed with necessary actions to implement the agreement, potentially impacting the company’s strategic operations and market positioning.
The most recent analyst rating on (HK:0367) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Chuang’s Consortium International stock, see the HK:0367 Stock Forecast page.
Chuang’s Consortium International Limited has announced a supplemental update to its annual reports for the fiscal years ending March 31, 2024, and 2025. The company is majority-owned by Evergain Holdings Limited, which holds a 56.77% stake and is considered the ultimate holding company. This announcement clarifies ownership details but does not alter any other information in the previously published annual reports.
The most recent analyst rating on (HK:0367) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Chuang’s Consortium International stock, see the HK:0367 Stock Forecast page.